Cannabinoid quinone derivatives
AssigneeVivacell Biotechnology Espana, S.L.
InventorsEduardo Muñoz Blanco, Giovanni Appendino, María Luz Bellido Cabello De Alba
Life of this patent
Estimating the term…
Abstract
Cannabinoid quinone derivatives. The present invention refers to cannabinoid quinone derivatives to be used as medicaments, particularly as PPAR gamma (PPARg) agonists for treating diseases which etiology is based on an impaired PPARg function as transcription factor i.e. PPARg-related diseases.
Claims8
Compound characterized by having the formula (VI):
A method for treating PPARg-related disease in a patient in need thereof that comprises administration to the patient of an effective amount of a pharmaceutical composition comprising a compound of Formula (VI):
Dependencies are inferred from the claim text.